Your browser doesn't support javascript.
loading
Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial.
Lehtinen, Matti; Apter, Dan; Eriksson, Tiina; Harjula, Katja; Hokkanen, Mari; Lehtinen, Tuomas; Natunen, Kari; Damaso, Silvia; Soila, Maaria; Bi, Dan; Struyf, Frank.
Afiliação
  • Lehtinen M; Department of Infections and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Apter D; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
  • Eriksson T; VL-Medi, Helsinki, Finland.
  • Harjula K; Faculty of Social Sciences, University of Tampere, Tampere, Finland.
  • Hokkanen M; Faculty of Social Sciences, University of Tampere, Tampere, Finland.
  • Lehtinen T; Faculty of Social Sciences, University of Tampere, Tampere, Finland.
  • Natunen K; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
  • Damaso S; Faculty of Social Sciences, University of Tampere, Tampere, Finland.
  • Soila M; GSK, Wavre, Belgium.
  • Bi D; GSK, Espoo, Finland.
  • Struyf F; GSK, Wavre, Belgium.
Int J Cancer ; 147(1): 170-174, 2020 07 01.
Article em En | MEDLINE | ID: mdl-31736068

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Orofaringe / Doenças Faríngeas / Infecções por Papillomavirus / Papillomavirus Humano 16 / Papillomavirus Humano 18 / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Orofaringe / Doenças Faríngeas / Infecções por Papillomavirus / Papillomavirus Humano 16 / Papillomavirus Humano 18 / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article